Literature DB >> 11423062

Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction.

D Poldermans1, F B Sozzi, J J Bax, E Boersma, D J Duncker, E Vourvouri, A Elhendy, R Valkema, J R Roelandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11423062     DOI： 10.1016/s0002-9149(01)01591-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

3.  Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement.

Authors:  T Zaglavara; T Pillay; H Karvounis; R Haaverstad; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

4.  The effects of beta-blockers on dobutamine-atropine stress echocardiography: early protocol versus standard protocol.

Authors:  Ana C Camarozano; Plínio Resende; Aristarco G Siqueira-Filho; Luis H Weitzel; Rosangela Noe
Journal:  Cardiovasc Ultrasound       Date:  2006-07-19       Impact factor: 2.062

5.  Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Jean Gf Bronzwaer; Cees A Visser; Frans C Visser
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.